are related to dose and volume, and the procedure can cause (transient) VS swelling, 10, 20 which is one reason that this therapy is generally avoided in large VSs. With the complete microsurgical removal of large VSs, a considerable risk of long-term suboptimal cranial nerve outcome arises, and good facial nerve function (HB Grade I or II) is reported in only 27%-58% of patients. 3, 22, 28, 38, 52, 62, 65 Controversy surrounds complete removal for tumor control versus subtotal removal for the preservation of facial nerve function in large VSs. If removed subtotally, these lesions do not usually stop growing. 2, 7, 14, 23, 24, 36, 40, 42, 45, 49, 54 Previous studies have revealed excellent long-term growth control with minimal risk to the cranial nerves after GKS for primary and residual VSs. 5, 11, 37, [43] [44] [45] 48 Therefore, in the management of large VSs, the combination of subtotal resection and GKS might be a logical treatment strategy to decrease the risk of both nerve damage and growth of residual VS. The authors of only four studies have reported outcomes following subtotal resection followed by GKS for large VSs, 12, 21, 42, 63 although the number of included patients was small 12, 21, 42 and only 2D measurements were performed, which are less reliable than volume measurements to evaluate tumor control. 59 The present study was conducted to evaluate the strategy of subtotal removal combined with GKS for large VSs, with special attention directed at clinical and radiological control, facial nerve preservation, and hearing function.
Methods

Patient Population
Patients who underwent planned subtotal VS resection together with postoperative GKS between January 1, 2002, and January 1, 2009, at the GammaKnife Centre Tilburg were analyzed retrospectively. The diagnosis of VS was confirmed histopathologically in all cases. The indication for surgery was a large VS indenting the brainstem, according to the Koos classification system. 26 Patients with Koos Grade III lesions underwent surgery after growth was seen after 1 year of follow-up, whereas an intervention without further follow-up was planned in patients with Koos Grade IV lesions (Fig. 1A) . The possibility of primary GKS was discussed preoperatively with patients harboring a VS smaller than 4 cm in the extracanalicular dimension and without symptomatic mass effect. They were informed about the diminished reserve for seeing VS growth or transient swelling after primary radiosurgery, possibly resulting in a higher chance of treatment failure. Vestibular schwannomas 4 cm or larger were considered to be poor candidates for primary GKS because some degree of symptomatic mass effect is usually present. The results of primary GKS for large VSs are published separately. 61 A surgical team consisting of a neurotologist and a neurosurgeon conducted most surgical procedures. Surgery was performed via either a translabyrinthine or a retrosigmoid approach, depending on surgeon preference, tumor size, and auditory function of the involved ear. The primary goal of surgery was brainstem decompression, and the facial nerve was identified using neurostimulation. The operating neurosurgeon was involved in the postoperative radiosurgical planning. Generally, microsurgery was continued until adequate brainstem decompression was achieved, to a volume well suited for GKS. The contour of the VS remnant was evaluated on the basis of neuronavigation. The operating team never continued to a full VS resection, and no internal auditory canal decompression was performed when operating retrosigmoidally. Postoperatively, all patients underwent GKS.
Surgical Technique
Stereotactic radiosurgery was performed using a Leksell Gamma Knife 4C (Elekta AB). Treatment planning was made with Leksell GammaPlan software (version 8.3.1). A dose of 12.0 to 13.0 Gy (mean 12.9 Gy) was prescribed to the isodose, covering 90% of the tumor volume. The maximum dose varied from 18.0 to 26.0 Gy (mean 21.1 Gy). The tumor margin dose varied from 9.4 to 11.9 Gy (mean 11.0 Gy). The number of isocenters per patient varied from 7 to 44 (mean 22.8 isocenters).
Clinical and radiological follow-up was planned for 3 months, 1 year, and 2 years after GKS and then once every 2 years thereafter if the tumor size shrank or was stable. A retrospective chart review was performed to evaluate clinical symptoms at presentation and after microsurgery and GKS. Audiometric assessments were performed in ac- cordance with the American Academy of OtolaryngologyHead and Neck Surgery guidelines, consisting of a mean pure tone average of 0.5, 1, 2, and 4 kHz and a speech discrimination score. According to these results, patients were assigned to hearing classes A, B, C, or D, where A and B are considered as serviceable hearing and C and D are not. 1 Facial nerve function was scored according to the HB scale 18 at the first visit to the outpatient department postoperatively and 1 year after GKS. Good postoperative facial nerve function was defined as HB Grades I and II.
One reader experienced in VS imaging performed all radiological examinations of axial Gd-enhanced (0.1 mg/kg body weight) T1-weighted MR images. The slice thickness was usually 1 or 2 mm without slice gap. Volumetric measurements were performed preoperatively, on the planning MR imaging, and after GKS. These volumes were calculated using Leksell GammaPlan 8.3.1 software. Central nonenhancement was defined as a hypointense area in the center of a VS on contrast-enhanced T1-weighted MR imaging that was not present before treatment and was scored as either absent or present. Cystic VSs were defined as VSs with enhanced cysts making up at least one-third of the nonenhancement of the tumor volume on contrast-enhanced T1-weighted and enhancing on T2-weighted MR images.
Radiological control was defined as VS regression or the absence of significant growth beyond a measurement error, which has been defined as a difference of 19.7% between subsequent scans. 59 Clinical VS control was defined as the absence of the need for further treatment (GKS or microsurgery) after subtotal resection and planned GKS.
Statistical Analysis
Absolute changes in volume were calculated by subtracting the VS volume at the time of GKS from its volume at the last measurement (volume at t x − volume at t 0 ). Relative changes in volume were calculated as the absolute change divided by the VS volume at the time of GKS (t 0 ): (volume at t x − volume at t 0 )/volume at t 0. This relative change was multiplied by 100 to obtain a percentage change in volume. A similar algorithm was used to determine the amount of residual VS tissue after surgery. The cumulative probability of clinical and radiological control was calculated using Kaplan-Meier analyses. Differences in mean values were tested for significance using the independent samples t-test. The Fisher exact and chi-square tests were used for categorical data. For all tests, p values ≤ 0.05 were considered to indicate statistical significance. All analyses were performed using SPSS 15.0 statistical software (SPSS, Inc.).
Results
Patient and Intervention Characteristics
There were 28 ). Further clinical and radiological features at presentation are featured in Tables 1 and 2 . Twenty-five patients (50%) underwent surgery via a retrosigmoid approach and 25 (50%) via a translabyrinthine approach. The mean time between microsurgery and GKS was 8.5 months (range 2-24 months). All patients underwent subtotal resection. The mean postoperative VS volume on the first follow-up MR image was 3.34 cm 3 (range 0.22-11.8 cm 
Clinical and Radiological Control
Clinical and radiological VS control was achieved in 92% and 90% of cases, respectively. The median follow-up was 33.8 months (range 12-84 months). The cumulative probability of clinical and radiological control is shown in Kaplan-Meier analyses (Figs. 2 and 3). One patient died of cardiac arrest during follow-up, 5 years after GKS. No patient-or VS-related characteristic-age, sex, lesion location, pre-or postoperative lesion size, central nonenhancement, presence of cystic components, surgical approach, and time between microsurgery and GKS-was predictive of clinical or radiological failure or a worse facial nerve outcome (p = not significant). Clinical treatment failure occurred after a mean of 31.5 months (range 22-49 months).
Of the 4 patients whose lesion showed significant growth, 3 underwent a second GKS treatment for residual VS, and thereafter, stability or a significant reduction in volume occurred during a median follow-up of 14.5 months (Table 3) . After the second GKS, 1 patient suffered from an HB Grade III transient facial nerve paresis. The fourth patient underwent a second microsurgical removal followed by GKS 49 months after the first resection because of progressing regrowth demonstrated on MR imaging despite the absence of clinical symptoms. This case involved a large VS remnant. Despite facial nerve monitoring and microsurgical precision, no facial nerve response was noted at the end of the operation due to facial nerve paralysis. A hypoglossal-facial nerve anastomosis was performed. One patient with significant lesion growth still undergoes a wait-and-scan policy 22 months after the first GKS.
Cranial Nerve Preservation
Good facial nerve function (HB Grades I and II) was preserved after microsurgery and GKS in 94% of the patients (Table 4) . Three patients ended up with an HB grade higher than II: one patient underwent hypoglossalfacial nerve anastomosis because of total facial paralysis, one patient underwent lateral tarsorrhaphy and gold implantation because of an HB Grade IV facial nerve paresis, and one patient received mime therapy because of HB Grade III function. The first patient had a large VS (extracanalicular dimension > 5 cm) where intraoperatively significant venous bleeding occurred. Despite surgical precision, facial nerve stimulation weakened intraopera-tively. The second patient suffered from a large compartmented cystic VS adherent to the cerebellum and brainstem. In the third patient, for an unknown reason facial nerve stimulation weakened when the upper part of the tumor was dissected, and thus surgery was stopped. At this point, a broad decompression had been performed. Postoperatively, a total paralysis was seen, although it improved to HB Grade III function after 1 year. In the 4 patients presenting with serviceable hearing, 2 underwent a retrosigmoid approach to attempt hearing preservation. At the last follow-up (37 months), 1 of 2 patients retained functional hearing.
Patient Complications
One major complication of hematoma formation occurred in a patient postoperatively due to a coagulation disorder that had not been discovered preoperatively; 2 revision surgeries were necessary to treat the hematoma. A permanent hemiparesis developed in this patient. Complications are presented in Table 5 . After GKS, an HB Grade II transient facial paresis developed in 2 patients. One patient demonstrated transient trigeminal hypesthesia. One patient experienced persisting facial nerve spasms for which botulinum toxin injections have been administered every 3 months, with good results.
Postradiosurgical Growth Patterns
After GKS, 3 residual VS growth patterns were identified: 1) shrinkage, which was subdivided into direct shrinkage (23 residual VSs (50%) showed central nonenhancement after GKS. Three (60%) of 5 patients with lesion growth demonstrated central nonenhancement, as compared with 22 (96%) of 23 patients without lesion growth; however, this difference was not significant (p = 0.70).
Discussion
The incidence of VS is increasing given the aging of the population and the increased use of and improvements in MR imaging. 55, 57 More patients are being treated conservatively in a wait-and-scan policy 8 in which audiovestibular symptoms are regularly monitored and VS size is observed with sequential MR imaging. The principle for this treatment is that some VSs do not grow or do so very slowly and intervention may not be necessary. 56 However, large VSs may cause life-threatening symptomatology, and a conservative approach is generally not recommended in these cases. Moreover, radiosurgery is rarely advised because of the risk of transient VS swelling, which can lead to increased brainstem compression and concomitant symptoms. Microsurgery is considered the treatment of choice in these cases. The general consensus on VS surgery is to perform complete tumor removal. But doing so carries a considerable risk of facial nerve damage, 3, 22, 28, 38, 52, 62, 65 which in turn severely affects quality of life. 6, 30 These factors inform the rationale for the combined treatment of large VSs in the present study. Vestibular schwannoma volume is reduced by planned subtotal microsurgical removal to avoid possible neurological deficits. Long-term growth control is achieved using planned GKS for residual VS. In addition, in cases with serviceable hearing, a better chance of hearing preservation might be realized after this combined treatment as compared with the results following complete resection of a large VS. 
Growth Control
In large VSs, complete lesion removal is advised 15, 38, 53 to prevent the growth of residual VS. After long-term follow-up, however, recurrences have been described in 7%-11% of patients following complete VS removal. 42, 45 This recurrence rate might be attributable to the fact that the anatomically intact facial nerves harbor schwannoma cells after surgery, as shown histopathologically. 4 In cases of subtotal resection, VS regrowth can occur in up to 53% of patients 2, 7, 14, 23, 24, 40, 45, 49, 54 and the chance of regrowth is considerably greater with increasing volumes of residual VS. 2 Lownie et al. 36 reported 18% regrowth after subtotal resection of large VSs. Park et al. 42 reported 11% regrowth after gross-total resection and 32% regrowth after subtotal resection of large VSs. Data in these studies indicate that the regrowth of subtotally resected VSs is an important issue, both for small/medium and for large VSs. Results after primary GKS in small/medium VSs are good, with growth control being documented in 87%-97% of patients. 5, 11, 37, [43] [44] [45] 48 Studies evaluating GKS in large VSs provide growth control varying from 54% to 100%, although drawing conclusions based on these results is difficult because of the small number of patients included in these studies. 16, 19, 29, 33, 39, 48, 50 Results of the present study indicate that both clinical and radiological control can be achieved with GKS after subtotal resection of large VSs. In our therapeutic regimen, GKS is not deferred until growth is seen after surgery, because in the past large VSs have demonstrated the ability to grow and may do so after surgery. Ninety-two percent of the patients did not undergo a second intervention, and 90% of the patients did not show significant lesion growth (Kaplan-Meier analysis; Fig. 3 ). These rates are superior to those in the literature on the use of subtotal resection alone, 2, 7, 14, 23, 24, 40, 45, 49, 54 and thus justify the use of GKS postoperatively.
Little is published regarding growth control in planned subtotal VS resection and GKS in large VSs (Table 6) . Fuentes et al. 12 reported on 8 patients and achieved lesion growth control in 100% of them with a mean follow-up of 46 months. Iwai et al. 21 studied 14 patients, including 2 with neurofibromatosis Type 2, and reported growth control in 79% during a mean follow-up of 32 months. Park et al. 42 described 8 patients who underwent subtotal resection and GKS, with a 100% control rate during a mean follow-up of 68.8 months. The largest study to date was performed by Yang et al. 63 They described a series of 61 patients with a median follow-up of 53.7 months. An 8-year control rate of 93.5% was documented, although some of their patients received GKS more than 7 years after surgery; it was not mentioned whether this late GKS was due to VS growth. All previously published studies on the subtotal resection of large VSs followed by GKS were performed with 2D measurements, which are less reliable than volume measurements to assess growth control. 59 The present study is the first to describe volumetric growth patterns in patients undergoing subtotal resection and planned GKS for large VSs. Three main radiological growth patterns were identified: shrinkage (58%), stability (32%), and growth (10%). Shrinkage was subdivided into direct shrinkage (46%) and transient swelling followed by shrinkage (12%). Growth consisted of continuous growth (8%) and shrinkage followed by regrowth (2%). Yang et al. 63 found radiological control in 94% of their cases, as compared with 90% in the present study. Note, however, that a direct comparison of the results is hampered by differences in the technique of volume measurements, that is, 2D versus volume measurements. Furthermore, differences in patient selection, radiosurgical technique, and duration of follow-up make direct comparison of the results troublesome, although the diminished accuracy in detecting growth by using 2D measurements might be the reason for the higher radiological growth control.
The growth patterns for subtotally resected VSs after GKS resemble the response of VSs following primary radiosurgery. 41 A transient increase in tumor volume occurred at a mean of 13.5 months (range 3-30 months) and should be distinguished from continuous growth to prevent unnecessary interventions. The presence of central * CG = continuous growth; FU = follow-up; NV = trigeminal hypesthesia; SR = regrowth after shrinkage. 
* Facial nerve function graded according to the HB facial nerve grading scale. † In only 2 of 4 patients with serviceable hearing was a retrosigmoidal approach performed. Table 4 .
nonenhancement did not prove to be a prognostic factor indicating growth control, in contrast to what has been previously hypothesized.
31,48
Facial Nerve Function
Although high rates of anatomical preservation have been published, functional outcomes in large series 1 year after complete resection of large VSs show HB grades of I or II in 27%-58% of patients 3, 22, 28, 38, 52, 62, 65 in whom the translabyrinthine 3, 28, 38, 62 and retrosigmoid 22, 52, 62, 65 approaches were performed (Table 7) . This is not surprising given that facial nerve outcome in surgery is inversely related to VS size. 27, 38, 42, 62 Furthermore, many patients in these series needed secondary facial nerve-related interventions. Mamikoglu et al. 38 reported that 19% of surgically treated patients needed cranial nerve VII-cranial nerve XII anastomoses and that 30% needed gold weights to achieve adequate eye closure. Two studies reported on facial nerve outcome after subtotal resection of large VSs: HB Grade I or II was obtained in 82% and 88% of patients, respectively. 36, 42 In large studies examining facial nerve function after primary GKS for small/medium VSs, dysfunction occurs in < 1% of cases; 5, 11, 37, [43] [44] [45] 48 however, when performing radiosurgery for large VSs, facial nerve dysfunction is seen more often. 39 Results of the present study indicate that the preservation of facial nerve function is possible after subtotal microsurgery combined with GKS for large VSs. Good facial nerve function was retained in 94% of the patients, and transient worsening of facial nerve function was observed after GKS in 2 of 50 patients. We showed that despite facial nerve monitoring and a "safe" subtotal resection, facial neuropathies can occur, as also demonstrated in previous studies. 36, 42 Intraoperative adverse events (such as excessive bleeding) or difficulties (adhesions) and cystic VSs (impeding a decent dissection) can cause these "failures." However, the percentage of patients with HB Grade I or II facial nerve function in the present study exceeds the less favorable results published elsewhere, in which complete resection of large VS was performed. In three other studies reporting on facial nerve outcome after subtotal resection and postoperative GKS, rates comparable with those in the present study were reported, varying from 85.7% to 95% (Table 6) .
12,21,63
Cochlear Nerve Function
Patients with large VSs may present with serviceable hearing, because hearing function is not related to VS size. 60 Hearing preservation rates following microsurgery performed for large VSs in an attempt to maintain hearing are rather disappointing, varying from 0% to 29% (Table 7) . 9, 17, 47, 51, 52, 62 It is clear that hearing preservation, like facial nerve function, is strongly related to tumor size. Some authors state that in large VSs, hearing preservation is unlikely and therefore should not influence the choice of surgical approach. 3, 28 In primary GKS for large VSs, the hearing preservation results vary from 38% to 94%. 19, 29, 33, 39 However, patient numbers are limited in these studies. Although speculative due to a small cohort (2 patients), the results of the present study indicate that serviceable hearing preservation is possible after subtotal resection and GKS for large VS. Hearing after subtotal resection and GKS for large VSs has been discussed only in the study by Yang et al.: 63 5 of 10 patients with serviceable preoperative hearing maintained serviceable hearing postoperatively and 3 of these 5 patients maintained serviceable hearing after subsequent treatment with GKS, but it was not specified how many of the 10 patients underwent hearing preservation surgery. Although no randomized controlled trial has been performed on the extent of VS resection and hearing preservation, the latter might be more likely when performing a subtotal resection rather than a complete resection, because traction and manipulation of the cochlear nerve is less likely to occur. In patients presenting with serviceable hearing in the context of a large VS, a retrosigmoid approach should be performed along with intraoperative auditory brainstem response monitoring to maintain a chance of hearing preservation.
Treatment Failure and Complications
Treatment failure occurred in 4 patients, and 3 of them were treated with a second GKS and 1 with a second microsurgical procedure followed by GKS for a larger residual VS. After a median follow-up of 14.5 months, the residual VSs remained stable or shrank. Previous studies have shown a good response after a second GKS for VS once the primary GKS has failed, with a very low risk of complications. 32, 64 One patient experienced an HB Grade III transient facial nerve paresis in the absence of lesion growth. One patient with a large progressive residual VS was surgically treated and had facial nerve paralysis postoperatively. Some authors find a higher risk of complications when dealing with additional surgery. 7, 58 In our experience, a second surgery was not necessarily related to a more difficult resection, as reconfirmed by others. 46 The number of complications during primary treatment was small (Table 5) . A major complication, hemiparesis, occurred in 1 patient. The incidence of minor complications was lower as compared with their incidence in previous studies of complete resection in large VSs, especially regarding CSF leakages, wound infection, and meningitis (Table 7) . 3, 22, 28, 38, 52, 65 A possible explanation for this is the decreased invasiveness and operating time of the resection. No studies have noted these complications following the subtotal resection of large VSs. No patient-or VSrelated features could be associated with the occurrence of complications or the failure to control VS growth.
Considerations and Limitations
Arguments against this combined technique might be that the patient is not completely cured in one operative session and that GKS might induce the malignant transformation of surrounding tissue. In our experience, patients do not present major symptoms after GKS and they can immediately resume their daily activities. The additional complications rate of GKS is low. The risk of malignant transformation has not been proven in a large study but should lie between 1 in 1000 and 3 in 200,000 treated patients. 13, 35 Gamma Knife surgery is widely used at present, with excellent follow-up results even in younger patients. 34 This study has some limitations. First, the follow-up time is relatively short. Given the median follow-up time (33.8 months) and the mean time of clinical failure (31.5 months), we acknowledge that a longer follow-up is necessary to draw definite conclusions. The second limitation is inherent to a retrospective study with data collection from medical records, which carries the risk of selection bias in the incidence of morbidity.
Conclusions
Given the good growth control and facial nerve function preservation, the possibility of preserving serviceable hearing, and the low number of complications, a subtotal resection followed by GKS can be the treatment option of choice in large VS. Hearing preservation is possible, but the number of patients with serviceable hearing in this study is too small to draw any conclusions.
